2021
DOI: 10.1016/j.jormas.2020.05.023
|View full text |Cite
|
Sign up to set email alerts
|

The omission of level IIB in early oral cancers: A word of caution

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
2
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 15 publications
1
2
0
Order By: Relevance
“…We certainly agree with their upcoming article 2 that level 1 evidence for omitting level 2b in neck dissections does not exist and should be approached with caution. Large‐scale, retrospective studies have shown that occult level 2b metastases occur in 0% to 15% of clinically negative ipsilateral necks and 0% to 2% of contralateral necks 3‐7 .…”
supporting
confidence: 63%
“…We certainly agree with their upcoming article 2 that level 1 evidence for omitting level 2b in neck dissections does not exist and should be approached with caution. Large‐scale, retrospective studies have shown that occult level 2b metastases occur in 0% to 15% of clinically negative ipsilateral necks and 0% to 2% of contralateral necks 3‐7 .…”
supporting
confidence: 63%
“…Secondly, Oikawa et al noted that all subsites of oral cancer may develop retropharyngeal lymph node metastasis and that although rare, level IIb could constitute the first echelon node due to metastatic spread via the retropharyngeal lymphatic pathway 52 , 53 . Thirdly, many studies emphasizing oncologic safety without dissecting level IIb seem to have overlooked the presence of micro-metastasis (MM) or isolated tumour cells (ITC) in the pN0 nodes 54 . In a recent study, the rate of MM was as high as 9% in pN0 cases, the risk being highest in level IB and IIA 55 .…”
Section: Discussionmentioning
confidence: 99%
“…We applaud Dziegielewski et al for meticulously collating an arduous trial, pointing out subtle details and generating a high level of evidence supporting the occurrence of shoulder dysfunction in patients undergoing submuscular recess dissections 1 . Although the literature supporting the omission of level 2b is fractionated, 2 to our knowledge studies have failed to provide concrete evidence with regard to oncological safety and long‐term shoulder dysfunction in avoiding submuscular recess dissection 3,4 …”
mentioning
confidence: 94%